Eye Health News and Research

Latest Eye Health News and Research

Comprehensive guide for clinicians to treat medical complications of bulimia

Comprehensive guide for clinicians to treat medical complications of bulimia

USC study shows missing brain protein may be responsible for severe over-worry and fear

USC study shows missing brain protein may be responsible for severe over-worry and fear

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Genetic abnormality linked to cancer four times more common in people with type 2 diabetes

Genetic abnormality linked to cancer four times more common in people with type 2 diabetes

Most patients willing to donate eyes for research, but few do

Most patients willing to donate eyes for research, but few do

Seven scientists to receive Annual Klerman and Freedman Prizes from Brain & Behavior Research Foundation

Seven scientists to receive Annual Klerman and Freedman Prizes from Brain & Behavior Research Foundation

UC Riverside professor receives grant to study potential treatment for age-related macular degeneration

UC Riverside professor receives grant to study potential treatment for age-related macular degeneration

Newcastle experts design DemTalk toolkit to help people with dementia

Newcastle experts design DemTalk toolkit to help people with dementia

Tel Aviv researcher says lessons from Israel's health-care system could optimize eye health

Tel Aviv researcher says lessons from Israel's health-care system could optimize eye health

Research suggests jealousy can prompt people to change themselves relative to competitors

Research suggests jealousy can prompt people to change themselves relative to competitors

Ohr Pharmaceutical enrolls first 60 patients in OHR-002 Phase II clinical trial for wet-AMD treatment

Ohr Pharmaceutical enrolls first 60 patients in OHR-002 Phase II clinical trial for wet-AMD treatment

visualFields package: A tool for analysis and visualization of visual fields

visualFields package: A tool for analysis and visualization of visual fields

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

Stem cells in the aesthetic industry: an interview with Dr. Norma Kassardjian

Stem cells in the aesthetic industry: an interview with Dr. Norma Kassardjian

vOICe sensory device: An alternative to invasive treatment for blind people

vOICe sensory device: An alternative to invasive treatment for blind people

EyeTechCare's EyeOP1 device to be installed in four healthcare facilities in France

EyeTechCare's EyeOP1 device to be installed in four healthcare facilities in France

Salk studies pave way to better computer object recognition and therapies for visual disorders

Salk studies pave way to better computer object recognition and therapies for visual disorders

Researchers identify two promising candidates for development of drugs to combat adenovirus

Researchers identify two promising candidates for development of drugs to combat adenovirus

African-American kids with T2D and risk for retinopathy are less likely to receive eye exam

African-American kids with T2D and risk for retinopathy are less likely to receive eye exam

Parents, children should leave fireworks displays to experts, say Vanderbilt specialists

Parents, children should leave fireworks displays to experts, say Vanderbilt specialists

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.